FDA approves Johnson & Johnson’s ketamine-derived nasal spray for depression as standalone treatment ...Middle East

Fortune - News
FDA approves Johnson & Johnson’s ketamine-derived nasal spray for depression as standalone treatment
The announcement was welcome news for those with major depressive disorder, affecting an estimated 8.3% of the adult population. Read More

Hence then, the article about fda approves johnson johnson s ketamine derived nasal spray for depression as standalone treatment was published today ( ) and is available on Fortune ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA approves Johnson & Johnson’s ketamine-derived nasal spray for depression as standalone treatment )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News


Latest News